• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[A simplified quick semi-quantitative determination of urinary estrogen in non-pregnant female: the application for monitoring of follicular maturation at HMG-HCG therapy].

作者信息

Kamata S

出版信息

Nihon Sanka Fujinka Gakkai Zasshi. 1986 Jan;38(1):64-72.

PMID:3081668
Abstract

We have developed a simplified quick semiquantitative determination for urinary estrogen in non-pregnant female by utilizing Amberlite XAD-2 and E3 LAIR-KIT. The whole procedure required only 20 minutes. Interassay variance of this method was 10% and intraassay variance was 7%. The recovery was 85%. There was a highly significant correlation between the data obtained by this method and those by RIA (r = 0.944). We applied this method to the monitoring of follicular maturation in the HMG-HCG therapy. Urinary estrogens obtained from 28 anovulatory women (60 cycles) were determined by this method in order to decide the appropriate timing for the HCG injection following the HMG. Our data indicate that it is possible to induce ovulation without the risk of ovarian hyperstimulation syndrome if the HCG was injected on the day when the urinary estrogen level rose to between 70 and 100 ng/ml for 2 consecutive days. This method could well be applied to prospective monitoring in ovulation induction with HMG-HCG therapy.

摘要

相似文献

1
[A simplified quick semi-quantitative determination of urinary estrogen in non-pregnant female: the application for monitoring of follicular maturation at HMG-HCG therapy].
Nihon Sanka Fujinka Gakkai Zasshi. 1986 Jan;38(1):64-72.
2
Experience with combined individualized method of hMG/hCG therapy.
Int J Fertil. 1983;28(2):85-90.
3
Monitoring of ovulation induction with HMG-HCG therapy by plasma estrogen and progesterone.
Int J Fertil. 1981;26(4):273-8.
4
Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.血清17β-雌二醇。促性腺激素治疗期间卵泡成熟指标。
Obstet Gynecol. 1978 Feb;51(2):204-9.
5
[Monitoring of follicles by ultrasonography during induction with HMG-HCG treatment--especially on the prevention of side effects].
Nihon Sanka Fujinka Gakkai Zasshi. 1985 May;37(5):721-9.
6
Ovulation induction with human menopausal gonadotropins.
Obstet Gynecol Surv. 1986 Aug;41(8):480-90.
7
Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin.人绝经期促性腺激素诱导排卵后发生的卵巢过度刺激综合征。
Int J Fertil. 1984;29(2):113-7.
8
Influence of serum progesterone levels at the time of hCG on the release of ova during hMG cycles.
Int J Fertil. 1992 Mar-Apr;37(2):103-5.
9
[The studies on the individualized treatment and hormonal patterns during the administration of HMG-HCG in anovulatory women (author's transl)].
Acta Obstet Gynaecol Jpn. 1981 Jun;33(6):777-85.
10
Ovulation induction with human menopausal gonadotrophins: an evaluation of a variable daily dosage regimen.
Int J Fertil. 1977;22(4):225-31.